Advertisement
Screener

Privia Health Group, Inc. (PRVA) Liability for Future Policy Benefits, Period Expense (Income)

2.8 / 5 stars · 68/120 Roast Me

Privia Health Group, Inc. Liability for Future Policy Benefits, Period Expense (Income)

Privia Health Group, Inc. (PRVA) reported Liability for Future Policy Benefits, Period Expense (Income) of $500.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:LiabilityForFuturePolicyBenefitsPeriodExpense · last filed 2026-08-06

  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2026-06-30 was $500.48M, a 23.27% increase year-over-year.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2026-03-31 was $475.12M, a 26.76% increase year-over-year.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2025-12-31 was $424.67M, a 20.25% increase year-over-year.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2025-09-30 was $455.21M, a 35.28% increase year-over-year.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2025 was $1.66B, a 24.63% increase from fiscal 2024.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2024 was $1.33B, a 2.62% increase from fiscal 2023.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2023 was $1.30B, a 23.55% increase from fiscal 2022.
  • Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2022 was $1.05B, a 44.41% increase from fiscal 2021.
Period endLiability for Future Policy Benefits, Period Expense (Income) 3 monthLiability for Future Policy Benefits, Period Expense (Income) 6 monthLiability for Future Policy Benefits, Period Expense (Income) 9 monthLiability for Future Policy Benefits, Period Expense (Income) 12 month
2026-06-30$500.48M
10-Q · filed 2026-08-06
$975.60M
10-Q · filed 2026-08-06
$1.40B
derived: sum of 3 quarters · filed 2026-08-06
$1.86B
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$475.12M
10-Q · filed 2026-05-07
$899.79M
derived: sum of 2 quarters · filed 2026-05-07
$1.35B
derived: sum of 3 quarters · filed 2026-05-07
$1.76B
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$424.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$879.88M
derived: sum of 2 quarters · filed 2026-02-27
$1.29B
derived: sum of 3 quarters · filed 2026-08-06
$1.66B
10-K · filed 2026-02-27
2025-09-30$455.21M
10-Q · filed 2025-11-06
$861.20M
derived: sum of 2 quarters · filed 2026-08-06
$1.24B
10-Q · filed 2025-11-06
$1.59B
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$405.99M
10-Q · filed 2026-08-06
$780.80M
10-Q · filed 2026-08-06
$1.13B
derived: sum of 3 quarters · filed 2026-08-06
$1.47B
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$374.81M
10-Q · filed 2026-05-07
$727.97M
derived: sum of 2 quarters · filed 2026-05-07
$1.06B
derived: sum of 3 quarters · filed 2026-05-07
$1.39B
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$353.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$689.66M
derived: sum of 2 quarters · filed 2026-02-27
$1.01B
derived: sum of 3 quarters · filed 2026-02-27
$1.33B
10-K · filed 2026-02-27
2024-09-30$336.50M
10-Q · filed 2025-11-06
$659.04M
derived: sum of 2 quarters · filed 2025-11-06
$979.37M
10-Q · filed 2025-11-06
$1.33B
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$322.54M
10-Q · filed 2025-08-07
$642.87M
10-Q · filed 2025-08-07
$992.25M
derived: sum of 3 quarters · filed 2026-02-27
$1.32B
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$320.34M
10-Q · filed 2025-05-08
$669.71M
derived: sum of 2 quarters · filed 2026-02-27
$994.94M
derived: sum of 3 quarters · filed 2026-02-27
$1.32B
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$349.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$674.60M
derived: sum of 2 quarters · filed 2026-02-27
$996.32M
derived: sum of 3 quarters · filed 2026-02-27
$1.30B
10-K · filed 2026-02-27
2023-09-30$325.22M
10-Q · filed 2024-11-07
$646.94M
derived: sum of 2 quarters · filed 2024-11-07
$949.20M
10-Q · filed 2024-11-07
$1.23B
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$321.72M
10-Q · filed 2024-08-08
$623.97M
10-Q · filed 2024-08-08
$908.34M
derived: sum of 3 quarters · filed 2025-02-27
$1.17B
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$302.25M
10-Q · filed 2024-05-09
$586.62M
derived: sum of 2 quarters · filed 2025-02-27
$851.80M
derived: sum of 3 quarters · filed 2025-02-27
$1.11B
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$284.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$549.54M
derived: sum of 2 quarters · filed 2025-02-27
$808.85M
derived: sum of 3 quarters · filed 2025-02-27
$1.05B
10-K · filed 2025-02-27
2022-09-30$265.17M
10-Q · filed 2023-11-03
$524.49M
derived: sum of 2 quarters · filed 2023-11-03
$766.67M
10-Q · filed 2023-11-03
$973.39M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$259.31M
10-Q · filed 2023-08-03
$501.50M
10-Q · filed 2023-08-03
$708.22M
derived: sum of 3 quarters · filed 2024-02-27
$898.27M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$242.19M
10-Q · filed 2023-05-04
$448.91M
derived: sum of 2 quarters · filed 2024-02-27
$638.96M
derived: sum of 3 quarters · filed 2024-02-27
$808.90M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$206.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$396.78M
derived: sum of 2 quarters · filed 2024-02-27
$566.71M
derived: sum of 3 quarters · filed 2024-02-27
$727.83M
10-K · filed 2024-02-27
2021-09-30$190.06M
10-Q · filed 2022-11-10
$359.99M
derived: sum of 2 quarters · filed 2022-11-10
$521.11M
10-Q · filed 2022-11-10
2021-06-30$169.94M
10-Q · filed 2022-08-11
$331.05M
10-Q · filed 2022-08-11
2021-03-31$161.11M
10-Q · filed 2022-05-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B